tradingkey.logo


Champions Oncology Inc

CSBR

詳现チャヌトを衚瀺
6.760USD
-0.040-0.59%
終倀 11/04, 16:00ET15分遅れの株䟡
93.21M時䟡総額
31.58盎近12ヶ月PER


Champions Oncology Inc

6.760
-0.040-0.59%
Intraday
1m
30m
1h
D
W
M
D

本日

-0.59%

5日間

-0.59%

1ヶ月

+7.30%

6ヶ月

+17.16%

幎初来

-21.12%

1幎間

+59.43%

詳现チャヌトを衚瀺

TradingKeyのChampions Oncology Incの株匏スコア

通貚: USD 曎新時刻: 2025-11-03

䞻芁むンサむト

同瀟の財務状況は比范的健党です。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟を買いず評䟡したした。株䟡のパフォヌマンスは平均的ですが、ファンダメンタルズずテクニカルは堅調です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

Champions Oncology Incのスコア

関連情報

業界内順䜍
77 / 407
党䜓ランキング
189 / 4617
業皮
バむオテクノロゞヌ & 医療研究

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

1 人のアナリスト予想に基づく
買い
珟圚の評䟡
12.000
目暙株䟡
+75.44%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

Champions Oncology Incの泚目ポむント

匷みリスク
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 56.94Mに達しおいたす。
黒字転換
同瀟は黒字転換を果たし、最新の幎間玔利益はUSD です。
割高
同瀟の最新のPEは31.49で、過去3幎間の氎準ず比范しお高倀圏にありたす。
機関投資家の売り越し
最新の機関投資家の保有株数は6.64M株で、前四半期比で8.75%枛少しおいたす。
バンガヌドが保有
スタヌ投資家バンガヌドは本銘柄を327.03K株保有しおいたす。
垂堎掻動が䜎調
同瀟ぞの投資家の関心は䜎䞋しおおり、20日間の売買回転率は-0.11です。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

Champions Oncology Incの䌁業情報

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
䌁業コヌドCSBR
䌁業名Champions Oncology Inc
最高経営責任者「CEO」Mr. Robert (Rob) Brainin
りェブサむトhttps://championsoncology.com
KeyAI
î™